Metraipolis › archive › dc_febd41bdc974

Investigating the treatment of vascular risk with simvastatin in secondary progressive multiple sclerosis: analysis from the MS-STAT2 randomized controlled… — Europe PMC PMID:42440661

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42440661
DOI
10.1093/braincomms/fcag240
License (as archived)
solo-consultazione
Archived
2026-10-19T04:25:52.005Z
SHA-256 of the archived text
7fbc1dc590863f9db99333a899849cf368419c637b98976be996cc6e3f819af2
Stable URL of this page
https://metraipolis.com/documento/dc_febd41bdc974

How to cite

Investigating the treatment of vascular risk with simvastatin in secondary progressive multiple sclerosis: analysis from the MS-STAT2 randomized controlled… — Europe PMC PMID:42440661 — Europe PMC (en), https://europepmc.org/article/MED/42440661 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_febd41bdc974 (Metraipolis archive dc_febd41bdc974, sha256 7fbc1dc590863f9db99333a899849cf368419c637b98976be996cc6e3f819af2)
BibTeX
@misc{dcfebd41bdc974,
  title = {Investigating the treatment of vascular risk with simvastatin in secondary progressive multiple sclerosis: analysis from the MS-STAT2 randomized controlled… — Europe PMC PMID:42440661},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42440661},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_febd41bdc974; sha256 7fbc1dc590863f9db99333a899849cf368419c637b98976be996cc6e3f819af2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42440661. Agents can read the archived copy with the MCP tool read_document.